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Summary 
Zoonotic infectious livestock diseases are becoming a significant 
burden for both animal and human health and are rapidly gaining the 
attention of decision-makers who manage public health programmes. 
If control decisions have only monetary components, governments are 
generally regarded as being risk-neutral and the intervention strategy 
with the highest expected benefit (lowest expected net costs) should 
be preferred. However, preferences will differ and alternative 
intervention plans will prevail if (human) life and death outcomes are 
involved. A rational decision framework must therefore consider risk 
aversion in the decision-maker and controversial values related to 
public health. In the present study, risk aversion and its impact on both 
the utility for the monetary component and the utility for the non-
monetary component is shown to be an important element when 
dealing with emerging zoonotic infectious livestock diseases and 
should not be ignored in the understanding and support of decision-
making. The decision framework was applied to several control 
strategies for the reduction of human cases of brucellosis (Brucella 
melitensis) originating from sheep in Turkey. 
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Introduction 
Nearly three-quarters of emerging and re-emerging livestock diseases 
are capable of causing disease in humans under natural transmission 
conditions (1) and are becoming a significant burden for society in 
general, and for agriculture in particular. In addition to emerging and 
re-emerging epidemics such as the epidemics of Q-fever and 
Bluetongue in northern Europe, endemic zoonotic diseases such as 
brucellosis, rabies and anthrax continue to be a major human disease 
burden worldwide. As a consequence, the control of zoonotic 
livestock diseases is rapidly gaining the attention of public and private 
decision-makers in public health programmes. 
Funding agencies increasingly require quantitative evaluation of the 
impact of public health programmes in order to meet increased 
demand for accountability (2). For governments and other funding 
agencies, resources are limited and not all potentially beneficial 
programmes for the control of emerging livestock diseases can be 
funded. Choices must be made, therefore, in the allocation of scarce 
resources among alternative programmes and intervention strategies. 
Such choices may entail trade-offs among conflicting interests and 
values; for example, the choice of a particular control strategy may 
involve a trade-off between the cost of intervention and the speed of 
eradication of the disease. Economic evaluation can help to make 
choices better informed, by comparing costs and consequences among 
alternatives. 
In making decisions on resource allocation, an often-used 
straightforward approach is to minimise the expected cost. The extent 
to which this can be done is contingent upon the constraints for the set 
of intervention strategies under consideration. The expected cost is 
calculated as a probability-weighted average of costs in different 
possible scenarios resulting from the intervention; for example, the 
constraints may capture the maximum accepted level of prevalence or 
a minimal required overall level of efficacy for each programme. As 
an alternative, efficacy can be maximised within the constraint of the 
budget; for example, the costs of an intervention and the benefits of its 
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impact can be evaluated in terms of the willingness of the public to 
pay to acquire the benefits or to avoid the costs (3).  
There are two fundamental limitations to this allocation approach 
when dealing with emerging zoonotic livestock diseases. The first 
limitation concerns the treatment of attitude to risk. Decisions about 
the control of livestock diseases are inherently risky, as the outcomes 
are uncertain and often involve downside risks. In particular, epidemic 
livestock diseases can be categorised as catastrophic risks with low 
probability of occurrence (rare events) leading to major and typically 
irreversible losses with a potentially adverse impact (severe events). 
For such catastrophic risks, the decision-maker may desire to avoid 
downside risks (risk aversion) instead of maximising average outcome 
(risk-neutral). As shown in the case of controlling contagious animal 
diseases, intervention strategies may be ranked differently when the 
decision-maker has different risk preferences (4). Choosing an 
intervention plan based solely on the expected outcomes does not take 
into account any non-neutral risk attitude of the decision-maker (5). 
Overlooking this essential component may result in flawed allocation 
of resources. 
To overcome the deficiency of ignoring risk preferences, the goal 
function can be rewritten to maximise the average utility. Utility is 
often used in economics as a representation of preferences, in this case 
for some set of risky intervention programmes for controlling the 
livestock disease. The expected utility of any such programme is 
derived as the weighted average of the utilities of all possible 
outcomes. However, if the decision has only monetary components, 
the government, and thus the policy-maker, should be regarded and 
advised as being a risk-neutral decision-maker. The key assumption 
about ignoring all but aversion to extremely large risks is that most 
risks are trivial when spread across the whole of society. 
The second limitation concerns the treatment of trade-offs between 
monetary values and non-monetary values such as human health and 
animal welfare. Intervention plans will be evaluated differently when 
(human) life and death outcomes are involved. Unlike research on 
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zoonotic animal diseases, which focuses on balancing costs and 
benefits, the focus in most research dealing with zoonotic issues is on 
minimising the risk of negative consequences. Part of the reason for 
this approach is the reluctance of analysts to quantify human sickness 
and possible death in economic terms. However, many decisions have 
such dimensions, and this also holds true about decisions on numerous 
emerging diseases. This aspect has to be included; for example, by 
means of disability-adjusted life years (DALYs) (6, 7, 8)]. The 
objective function can be to maximise the number of DALYs that are 
averted, but whether or not this can be achieved is contingent upon the 
global budget constraint for the set of livestock intervention strategies 
under consideration. The utility function can be formulated in such a 
way that it also captures these non-monetary elements. 
In summary, decision-making in the control of zoonotic diseases is a 
complex process, characterised by conflicting epidemiological, 
economic and socio-ethical value judgments. The utility function and 
the constraints should accommodate these specific emerging features 
in order to support policy-makers in choosing the intervention strategy 
that best meets all these conflicting judgments. The goal of the present 
study was to incorporate risk aversion for the monetary component 
and the utility for the non-monetary component when dealing with 
emerging zoonotic infectious livestock diseases. To highlight the 
importance of risk aversion in the decision-making process, several 
control strategies to reduce human cases of Brucella melitensis 
brucellosis originating from sheep in Turkey were evaluated. Possible 
ways to include risk aversion in the analysis are illustrated and 
discussed. 
Decision framework including risk attitude and 
non-monetary values 
Chance events can have an important impact on the success of an 
intervention programme and its overall cost, so decision-makers must 
take these potential events into account when deciding upon the 
optimal strategy. A low probability of an unfavourable outcome might 
be associated with dramatic losses, and the possibility of such a 
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potentially serious outcome emphasises the importance of risk 
assessment to quantify the probability of possible differing overall 
costs. Including the possibility of these types of event in a stochastic 
setting is an important technique in risk analysis (5, 9). 
Modelling trade-offs 
Once the distributions of the overall costs of all intervention 
alternatives have been determined, the decision-maker is able to rank 
the alternatives on the basis of certain efficiency criteria. The 
alternatives can be divided into an economically efficient set and an 
economically inefficient set. The inefficient set contains those 
alternatives that are dominated by alternatives in the efficient set; for 
example, by an alternative that has the same level of risk but is less 
costly. The optimal alternative for the decision-maker will lie among 
the alternatives on the economic efficiency frontier (5). The frontier 
contains each alternative for which there is no other alternative with 
the same or lower mean costs and the same or lower risk. As an 
illustration, the mean costs of three hypothetical alternative control 
programmes (denoted by J, K, L) and the associated risk (e.g. variance 
of costs) are shown in Figure 1. Alternatives K and J are not 
dominated by any other alternative and are therefore efficient. 
Alternative L is inefficient because J and L are indifferent with respect 
to the amount of risk (Xjl) but the expected benefits are higher since 
average costs are lower for J (Yj<Ykl). Alternatively formulated, K 
and L are indifferent with respect to the expected benefits (Ykl), but L 
is riskier (Xk < Xjl). Within this concept, risk is included for 
discriminating among efficient risky alternatives. Risk as variability 
can be approximated by some statistic of dispersion of the distribution 
of economic outcomes. Variance is the most commonly used risk 
parameter resulting in expected value variance (EV)-based efficiency 
frontiers. 
**Insert Fig. 1** 
The analysis of alternative control programmes for bovine 
tuberculosis is a typical example of these efficiency curves applied to 
an emerging livestock disease in a particular country (10). The use of 
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efficiency curves to evaluate intervention options for pathogen 
reduction technologies in cattle slaughter plants is one such example 
(11). 
In general, determining the efficiency frontier is complicated, because 
many alternative schemes need to be evaluated within a stochastic 
structure (5). Several different models have been used for the budget 
problems outlined above, with mathematical programming 
predominating. The form of such programming models ranges from 
quadratic (EV) risk programming (12) to direct maximisation of the 
expected utility via nonlinear programming (13, 14). Determination of 
the efficient frontier for control problems in emerging zoonotic 
livestock diseases should be based on the benefit to society as a whole 
in utility terms, comprising the impact of intervention strategies on 
livestock production losses as well as human health costs and income 
losses. 
For simplicity, the current hypothetical example focuses on a limited 
number of alternative intervention strategies; therefore a simulation 
approach for the evaluation of these limited strategies is a viable 
option. In case continuous decision options need to be evaluated (e.g. 
the proportion of animals tested or vaccinated), then optimisation is 
the approach for finding the optimal solution among infinite options. 
The stochastic structure is estimated using a Monte Carlo stochastic 
simulation approach. A Monte Carlo simulation model is used to 
obtain insight into the distribution of the impact of an emerging crisis 
in a zoonotic livestock disease and to evaluate alternative intervention 
strategies. With stochastic simulation, random values are sampled 
from various distributions to represent the chance events. Combining 
the results of each iteration will lead to a distribution of output values 
(15, 16). Comparison of the simulation results of the alternative 
schemes can be used to determine the optimal alternative that is 
consistent with the risk attitude of the decision-maker. However, 
many iterations per simulation have to be run before a reliable 
overview of the output probability distribution is represented. As more 
iterations are run, the output becomes more stable, because the 
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statistics describing each distribution change less and less until they 
converge. 
Since the number of alternative intervention strategies is limited, the 
optimal control strategy is determined via ranking. This is in contrast 
to a situation where a large number of alternative control strategies 
need to be evaluated and in which risk programming models such as 
quadratic (EV) risk programming (12) or utility-efficient 
programming can be applied. 
The risky alternatives are ranked on their certainty equivalents by 
applying the following function: 
Equation 1: 
OaO VrE=CE 5.0  
where ra is the absolute risk aversion, V is the variance of a certain 
outcome (O) parameter and E is the expected outcome. A certainty 
equivalent can be defined as the sum of money to which a decision-
maker is indifferent when facing the risk or accepting the sure sum. 
For ease of understanding, the relative risk aversion (rr) is depicted in 
the illustrations, where ra=rr/max and max is the maximum possible 
loss in the example. The inflated outcome is assumed to have the 
following notation: 
Equation 2: 
t
vtfhtlt
T
t d
cpXccBcY
=O

1  
where Y is the proportion of infectious seropositive animals in year t, 
c represents losses per seropositive animal (cl), B is the number of 
newly reported human cases and ch is the cost per newly reported 
human case. The costs of the intervention strategies under study 
comprise fixed costs for the organisation (f) and variable costs (v) that 
differ in accordance with the proportion (p) of the number of 
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susceptible animals (X) tested/treated for a given planning horizon T; 
d is the monetary discount rate.  
In the following section on model structures, the impact of an 
emerging disease is described and alternative intervention options and 
stochastic elements are explored in more detail. 
Modelling transmission and the health impact 
Not all intervention strategies are as effective at controlling diseases 
as others. To illustrate the impact of strategy choice on the control of a 
hypothetical zoonotic disease in animals and humans, a basic 
susceptible-infected-recovered (SIR) model was applied (17, 18). The 
differential equations are shown in Equations 3 to 7; it was assumed 
that animal-to-human transmission was caused by only one animal 
species and that human-human transmission was not likely to occur. 
The intervention strategies that served as an example focused on 
testing and culling or vaccination of susceptible livestock. 
The compartment of newly susceptible animals (X), see Equation 3, 
comprises: (i) those animals losing their immunity (where Y is the 
number of seropositive animals and ε is the immunity-loss constant), 
(ii) susceptible offspring (where αl is the birth rate of the given 
livestock, η is decreased fertility of seropositive animals Y, and Z is 
the number of immunised animals), or (iii) those losing their 
vaccination protection (where τ is the inverse duration of vaccination 
protection). Deducted from this group were: (i) deceased animals 
(where μl is the livestock culling rate, either voluntary or involuntary), 
(ii) animals becoming seropositive (where γ is the proportion of 
infectious seropositive animals and βl is the animal-to-animal 
transmission rate), or (iii) animals being vaccinated (where p is the 
proportion of animals vaccinated and v is the vaccine efficacy). 
Equation 3: 
ZpvXXYX lll   )))ZYX
Y(-Z)(1Y(X(Y
dt
dX
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The compartment of newly seropositive animals comprises those 
becoming seropositive minus those losing their immunity, deceased, 
or culled as a result of a testing intervention (T) strategy. 
Equation 4 
TYYYXY ll  dt
dY
 
Note that Equations 3 and 4 can be rewritten to take into account the 
specificity and sensitivity of the test applied. 
The compartment of newly immunised animals comprises animals 
being vaccinated minus those deceased or losing their immunity. 
Equation 5: 
ZZpvX  
dt
dZ
 
The compartment of newly susceptible humans (A), as in Equation 6, 
comprises susceptible infants (where αh is the birth rate of the human 
population under investigation) minus newly reported cases (βh is the 
livestock-to-human transmission rate) and deceased individuals 
(where μh is the human mortality rate). 
Equation 6: 
AAYBA hhh   )(dt
dA
 
The differential equation for newly reported human cases (B) 
comprises those becoming infected minus the deceased. 
Equation 7: 
BAY hlh  dt
dB
 
On the basis of the estimated numbers of reported cases, the 
associated human health costs and income losses can be derived, as 
well as the value of the overall non-monetary component of the 
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disease burden. The latter aspect is included in the present study by 
means of DALYs (6, 7) and is designed to quantify the impact of 
premature death and disability on a population by combining them 
into a single, comparable measure (6, 7). The number of DALYs is 
calculated by taking the sum of the expected years of life lost (YLL) 
and the expected years lived with disability (YLD) (Equation 8). The 
DALY relies on an acceptance that the most appropriate measure of 
the effects of chronic illness is time, both time lost because of 
premature death and time spent disabled by disease. One DALY, 
therefore, is equal to one year of healthy life lost. 
Equation 8: 
)()()( YLDEYLLEDALYE   
The YLL basically corresponds to the number of deaths multiplied by 
the standard life expectancy at the age at which death occurs. 
Equation 9: 
LNLL Y  
where N is number of deaths and L is the standard life expectancy (in 
years) at age of death. Because YLL measures the incident stream of 
lost years of life as a consequence of deaths, an incidence perspective 
is also taken for the calculation of YLD. 
Equation 10: 
LDWBLD Y  
where B is the number of incident cases, DW is the disability weight 
on a scale from 0 (perfect health) to 1 (death), and L is the average 
duration of the case (in years) until remission or death. 
Input assumptions 
Brucellosis is endemic in Turkey. The infection is transmissible 
between animals and humans and therefore imposes a burden on both 
animal and human health. The prevalence of the disease not only 
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limits productivity in the livestock sector and impairs the health of the 
Turkish human population but also prevents the country from 
accessing high-potential export markets. In animals, brucellosis 
mainly affects reproduction, reduces survival rates for newborns and 
reduces milk yield and meat production. Human cases of brucellosis 
can have a bovine (B. abortus) or ovine and caprine (B. melitensis) 
origin. The framework was applied to several control strategies for 
reducing human cases of brucellosis originating from sheep. Human 
brucellosis cases are not typed according to the causative agent, thus 
the challenge was to distinguish between human cases resulting from 
infection with B. abortus and those resulting from infection with B. 
melitensis. For the purposes of the study it was assumed that 70% of 
the human cases were of ovine origin and 30% were of bovine origin. 
These assumptions were based on the results of a project that had been 
funded by the Dutch Ministry of Agriculture in cooperation with the 
Turkish Ministry of Agriculture: ‘Support for the general strategy for 
the brucellosis and bovine tuberculosis control in Turkey’ (19). 
To keep the allocation task within bounds, three control strategies 
were compared. The first was a test-and-cull strategy (T) in which 
one-third of the herd is tested every year and animals that test 
seropositive are culled. The second was a variant of the test-and-cull 
strategy, in which all the animals are tested every year and 
seropositive ones are culled. The third was a vaccination strategy in 
which all new young animals in the herd are vaccinated. The default 
simulation served as the reference strategy and was used to calibrate 
the model parameters. A constant prevalence was assumed (i.e. a 
steady-state situation in the past and for the future). The evaluation 
was based on a 10-year period and a monetary discount rate of 5% 
was used. More detailed information on test and vaccine 
characteristics and on epidemiological and economic inputs are given 
in Table I. Country-specific data were retrieved from the Ministry of 
Agriculture project mentioned above (19). A large quantity of data has 
been collected in this study on the eradication of brucellosis and 
tuberculosis; for example, in the serological survey estimating the 
prevalence of brucellosis in cattle, sheep and goats (herd prevalence 
and individual prevalence). Human cases are also analysed in this 
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study. The human health costs take into account the benefit resulting 
from avoidance of out-of-pocket payments for hospitalisation and loss 
of income (opportunity costs) per infected case. A number of 
parameters used in the dynamic model are based on data from the 
literature and on expert opinion; in particular, data from Roth et al. 
(17). 
The software @Risk (Palisade Corporation, USA) was used in the 
simulation model and different functional forms were embedded to 
capture the risk. Thus, riskiness was captured by stochastic 
transmission parameters included in the SIR model; namely, decrease 
of fertility, proportion of infectious seropositive animals and inverse 
duration of vaccination protection. To establish stable probability 
distributions, 10,000 replications were run, each comprising an 
outcome for a ten-year period. For ease of understanding, randomness 
was ignored with respect to parameters of livestock production and 
price. 
Results 
All three intervention strategies resulted in lower levels of prevalence 
than those that would have been expected had there been no control 
efforts. However the strategies differed with respect to their levels at 
the end of the planning horizon and in the rapidness of their descent. 
The prevalence in sheep decreased most rapidly with the test-and-cull 
strategy where all the animals were tested before culling of the 
seropositive ones (Fig. 2). For each strategy, the impact on herd 
prevalence directly affected the descent and final level of human 
prevalence (Fig. 3). 
***Insert Fig. 2 and Fig. 3*** 
As mentioned above, chance events can have an important impact on 
the success of an intervention strategy, so they must be taken into 
account when designing a control programme. The possibility of a 
potentially serious adverse outcome emphasises the importance of a 
risk assessment to quantify the probability of the different overall 
average outcomes. The key mean results are shown in Table II. 
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**Insert Table I** 
The simulated results of the strategies for controlling B. melitensis in 
sheep show that the intervention costs are substantially larger for both 
the test-and-cull strategies than for vaccinating all young animals. 
The cost-benefit ratio summarises the overall value for money of the 
alternative intervention strategies, expressed in present monetary 
values. The benefits relative to their costs differ substantially. The 
reduction in human costs and production losses more than offsets the 
intervention costs of vaccinating a proportion of the population, 
thereby creating a predicted net gain. However, with the test and 
culling strategies, for every euro spent, less than one euro is received 
in the form of livestock or human benefits. 
A sensitivity analysis indicated the prevalence and testing costs at 
which it becomes cost-effective to switch to another strategy. Even at 
the relatively low levels of prevalence in Turkey, vaccination is 
preferred over test-and-cull strategies, because the cost of vaccination 
is relatively low and the cost of culling is relatively high. However, 
the general opinion is that, if the seroprevalence of brucellosis is 
below 1%, test-and-cull may be implemented (20). Nevertheless, our 
research shows that, based on economic evaluation only (given the 
high costs of testing and compensation in the test-and-cull strategy), 
the relatively low cost of vaccination is still the preferred strategy, 
even at low seroprevalence.  
In a country at a certain stage of the disease control programme, a 
decision might be taken to change from control to eradication, 
provided that additional advantages, such as access to new markets, 
outweigh the cost of reintroduction of the disease. In countries where 
moving animals within the country and (illegal) import are part of 
agricultural production, the risk of reintroduction and subsequent 
spread of the disease in a naive population outweighs the economic 
benefits of being free of disease for a period of time. The 
consequences of reintroduction in a (partially) protected population 
are substantially less than in a naive population. 
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Ultimately, the net result per averted DALY quantifies the cost per 
non-monetary unit saved for the society as a whole. In encouraging 
governments to support allocation of funds to the veterinary sector for 
controlling the animal reservoir, the classic cost-effectiveness measure 
of monetary units per averted DALY, sometimes referred to as cost-
utility analysis, is regarded as very persuasive (21, 22). Again, all on-
going monetary costs of treating people and animals, as well as the 
income losses in affected families, should be compared with the 
accrued benefits. Positive values indicate net benefits of an 
intervention strategy stemming from reduced losses in the livestock 
sectors, but patients are also beneficiaries (avoiding out-of-pocket 
losses and income loss). 
Inherent within this framework are two deficiencies: namely, ignoring 
the (downside) risk associated with the monetary part of the equation 
and the riskiness in the non-monetary unit (i.e. DALY) in relation to 
risk aversion. Under the assumption that decision-makers are risk-
averse, a utility-based approach should be followed. 
Economic efficiency criteria 
The probability distribution of the estimated benefits revealed a 
skewed distribution indicating a substantial downside risk. These 
stochastic economic outcomes stem from the imposed random 
variables in the SIR model. 
The test-and-cull control alternatives are dominated by the vaccinating 
strategy (Fig. 4). Since the vaccination strategy comes with the lowest 
cost and lowest risk, it will be preferred irrespective of the risk 
attitude of the decision-maker. If vaccination is not a feasible solution, 
and thus test-and-control strategies have to be relied on, then the 
optimal decision depends on the risk attitude of the decision-maker. 
Give this exclusion, the efficiency frontier includes both of the test-
and-cull strategies. The chosen alternative will ultimately depend on 
the attitude to risk; a more costly control scheme will be enforced (test 
all animals) if the expected outbreak size is to be constrained. 
**Insert Fig. 4** 
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Further analysis by calculating certainty equivalents at alternative 
risk-aversion levels reveals that risk-neutral as well as extremely risk-
averse decision-makers will prefer the strategy of testing one-third of 
the animals annually. 
Precise definitions of benefits and costs complicate the economic 
efficiency criteria. In particular, the valuation of human sickness and 
possible death is difficult to ascertain, as non-monetised impacts and 
the associated risk aversion are ignored. 
Disability-adjusted life year efficiency criteria 
If the merit of an intervention strategy is solely evaluated in non-
monetary terms, such as a DALYs framework, other strategies might 
prevail. The DALY efficiency frontier (Fig. 5) shows that all 
alternatives are dominated by one efficient alternative. Testing all 
animals and subsequently culling the seropositive animals is 
associated with the lowest expected DALY benefit as well as the 
lowest variability in the DALY outcome. 
**Insert Fig. 5** 
Evaluating a strategy solely on the basis of a DALY criterion would 
imply selecting the strategy that most reduces the certainty equivalent 
in terms of DALYs, and requires information on the level of risk 
aversion for this non-monetary component. However, the preferred 
strategy is not affected by the level of risk aversion, since it is 
associated with the lowest variability in the DALY outcome. Under 
the assumption that decision-makers value the monetary and non-
monetary component, a joint evaluation is more appropriate. 
Multi-efficiency criteria 
To overcome the limitations mentioned above, the economic 
efficiency criteria should be combined with information on those 
impacts that cannot be expressed in monetary terms but can be 
expressed in the DALY efficiency criteria. There are four evaluation 
variables to be considered in this joint efficiency-frontier concept: 
certainty equivalent in monetary units, certainty equivalent in non-
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monetary units, risk aversion for monetary units, and risk aversion for 
non-monetary units. In order to illustrate the relationship between 
these four evaluation variables by means of a two-dimensional 
coordinate system, two evaluation variables have to be stationary; for 
example, the joint efficiency frontier depicted in Figure 6, given a 
rather risk-averse decision-maker (23), with respect to both monetary 
(Rrm=2) and non-monetary (Rrh=2) dimensions. 
Half of the control alternatives are dominated by alternatives in the 
efficient set. Vaccinating all young animals is optimal if the decision 
is based solely on an economic rationale. However, if non-monetary 
issues are considered to be the only important issue, then testing all 
the animals is preferred. The chosen alternative will ultimately depend 
on the importance of monetary issues relative to non-monetary issues. 
**Insert Fig. 6** 
Discussion 
The importance of risk aversion and the non-monetary component 
when dealing with (emerging) zoonotic infectious livestock diseases 
has been shown in the present study. To understand and support 
decision-making, these components should not be ignored. The 
framework applies equally to endemic zoonotic diseases that have 
been prevalent for decades or even centuries and, although it is disease 
specific, the framework can be applied to developing, transition and 
developed countries. However, in a situation of a stable prevalence of 
a livestock disease, the impact of risk aversion is less profound, 
although accounting for the non-monetary component does affect the 
allocation of budgets for the control of livestock diseases. 
In this study a simple utility function was used to capture risk 
aversion. Using alternative forms of utility function might affect the 
ranking of risky alternatives and it would be interesting to explore this 
aspect in the future. Forms of utility function that are widely used in 
risk modelling are, for example, the negative exponential function, 
logarithmic and power utility functions, and polynomial-exponential, 
quadratic and hyperbolic absolute risk aversion utility functions (5, 
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24). However, one disadvantage of the utility approach is its 
complexity. The elicitation procedure is judged as fairly difficult: 
there is evidence that the functions obtained are vulnerable to bias 
both on the part of the interviewer and from the way the questions are 
framed (5). Instead, to avoid the practical problems of utility theory 
with respect to elicitation of risk attitude, assumptions about the 
nature of the utility function (based on the literature) can be imposed, 
as in the current study. 
In the current example, a simple utility function for both monetary and 
non-monetary aspects was applied, which might be an over-
simplification of the risk preference of the decision-maker. Moreover, 
the utility function might also differ among alternative stakeholders. 
For example, representatives of the authorities who are responsible for 
crisis management might value a risky prospect differently than 
representatives of livestock industries. However, for successful 
implementation of a control plan, close collaboration of the various 
responsible agents is vital. The efficacy of prospective intervention 
strategies is important, but so are the costs and benefits that various 
groups in society are likely to incur or derive. This is also true for the 
expected cost and benefit allocation and for the risk of more adverse 
outcomes for specific agents. 
Decision-making in the eradication of emerging diseases is a process 
of conflict between monetary and non-monetary value judgments. 
Mourits et al. used a multicriteria decision-making (MCDM) 
application to illustrate its potential support to policy-makers in 
choosing the intervention strategy for epidemic livestock diseases that 
best meets all the conflicting interests (25). Different stakeholders will 
have different ideas about which strategy to choose; for example, their 
views may represent the interests of the farming community, the 
processing industry, the animals, the consumer or the general citizen. 
Thus, economic motives may prevail in the views of some parties and 
animal or human welfare motives may be prominent in the view of 
others. There might also be regional differences in the order of 
priorities (26). Mourits et al. assumed a maker attitude with respect to 
intervention in contagious animal diseases, since the MCDM analyses 
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were directed toward the outcomes of the iteration resulting in the 
95th percentile value of the performance score size of an outbreak; 
this is a rudimentary approach. But also with MCDA, any utility 
function can be introduced to take into account the phenomena of risk 
aversion. Elicitation of risk preferences and preferences amongst 
conflicting interests is even more difficult with MCDA, since this 
application normally focuses on numerous conflicts; the current 
approach aggregates these into two conflicting interests and risk 
preferences, namely a monetary component and a non-monetary 
component. 
In summary, accounting for risk aversion and non-monetary values in 
the decision-making process for the control of zoonotic livestock 
diseases is essential. The presented framework can be used to advise 
decision-makers in a way that is more transparent, objective and 
consistent. 
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Table I 
Modelling the impact of intervention strategies on the control of 
zoonotic animal diseases: compartments and input parameters for 
the hypothetical example of brucellosis in Turkey 
Variables Value Description 
Composition   
X  28,325,138 Number of susceptible sheep 
Y  1,057,785 Number of seropositive sheep 
A  76,805,524 Number of susceptible humans 
B  5,024 Annual number of newly reported human cases  
Epidemic parameters   
ŋ Uniform (0.125, 0.175) Decrease in fertility 
γ Uniform (0.45, 0.55) Proportion of infectious seropositive sheep 
βl  6.59E-08 Sheep transmission rate  
βlh  1.27E-10 Sheep-to-human transmission rate 
Αl  0.90 Sheep birth rate  
Αh  0.02 Human birth rate 
Μh  0.02 Human mortality rate 
Εl  0.00 Sheep immunity loss constant 
μl  0.90 Sheep culling rate  
VacEff  0.65 Vaccine efficacy 
τrev1 Uniform (0.22, 0.26) Inverse duration of vaccination protection 
SE  0.75 Sensitivity 
SP  1.00 Specificity 
d  1.05 Monetary interest and human discount rate 
Economic inputs   
Lamb value  400.00 Price (TL) per lamb  
Sheep weight  40.00 Average live weight (kg) for sheep  
Meat reduction in sheep  0.05 Fraction of reduction in mutton production 
Meat price in sheep  14.00 Meat off-farm: price (TL) per kg live animal  
Percentage ewes  0.70 Percentage of breeding ewes 
Sheep loss  28.00 Productivity loss (TL) per sheep  
Testing cost  11.00 Testing cost (TL) per sheep 
Vaccination cost  0.40 Cost (TL) of vaccination per sheep  
Organisation cost  1.00 Cost (TL) to the organisation per sheep 
Compensation cost  500 Compensation (TL) per seropositive sheep culled  
DALY case  0.90 Average DALY per human case 
Human health costs  2280.00 Human health costs (TL) per DALY  
DALY: disability-adjusted life year 
TL: Turkish Lira (exchange rate: 1 Turkish Lira = 0.37 Euro) 
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Table II 
Key results (expressed as means) of strategies for controlling 
brucellosis in sheep 
Description of control scenario 
Test-and-cull 
1/3 animals 
Test-and-cull 
all animals 
Vaccination of all 
young animals 
Effectiveness of the strategy    
Prevalence (%) in sheep and goats in year 10  0.27 0.00 0.06 
Incidence of infection of ovine origin in humans in year 10 
(per 100,000 people) 
0.61 0.00 0.17 
   
Costs 
Intervention costs (million TL) 1,600 3,971 226 
Benefits 
Agricultural loss averted (million TL) 437 631 463 
Human costs averted (million TL) 50 74 53 
DALYs averted (in 1,000) 20 29 21 
Ratios 
Intervention costs per DALY averted (in 1,000 TL) 81 136 11 
Cost-benefit ratio in agriculture 0.27 0.16 2.05 
Cost-benefit ratio total 0.30 0.18 2.29 
DALY: disability-adjusted life year 
TL: Turkish Lira (exchange rate: 1 Turkish Lira = 0.37 Euro) 
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Fig. 1 
Efficiency frontier of control strategies for emerging livestock 
diseases 
Average costs (Y) of three hypothetical alternative control 
programmes (denoted by J, K, L) and the associated risk, e.g. variance 
of costs (X) 
Risk
Average total costs
J
K L
Ykl
Xjl
Yj
Xk0
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Fig. 2 
Effect of intervention strategies on the prevalence of brucellosis in 
sheep over a 10-year planning horizon 
A hypothetical example of brucellosis in Turkey 
No intervention 
Test-and-cull strategy (1/3 of all animals annually) 
Test-and-cull strategy (all animals annually) 
Vaccination of all young animals 
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Fig. 3 
Effect of intervention strategies in sheep on the incidence of 
human brucellosis over a 10-year planning horizon 
A hypothetical example of brucellosis in Turkey 
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Fig. 4 
Economic efficiency of control strategies for emerging livestock 
diseases 
A hypothetical example of brucellosis in Turkey 
 
TL: Turkish Lira (exchange rate: 1 Turkish Lira = 0.37 Euro) 
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Fig. 5 
Disability-adjusted life year (DALY) efficiency of control 
strategies for emerging livestock diseases 
A hypothetical example of brucellosis in Turkey 
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Fig. 6 
Efficiency with respect to monetary and human components 
 
CE: certainty equivalent 
DALY: disability-adjusted life year 
TL: Turkish Lira (exchange rate: 1 Turkish Lira = 0.37 Euro) 
